ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $3,287,000 | +37.1% | 19,100 | 0.0% | 2.57% | +77.9% |
Q2 2021 | $2,397,000 | -7.5% | 19,100 | 0.0% | 1.44% | +10.6% |
Q1 2021 | $2,590,000 | +6.0% | 19,100 | 0.0% | 1.31% | +1.6% |
Q4 2020 | $2,444,000 | +13.7% | 19,100 | 0.0% | 1.29% | +112.6% |
Q3 2020 | $2,149,000 | +182.0% | 19,100 | +138.8% | 0.60% | +152.1% |
Q2 2020 | $762,000 | +6.0% | 8,000 | 0.0% | 0.24% | +20.6% |
Q1 2020 | $719,000 | +69.6% | 8,000 | 0.0% | 0.20% | +158.4% |
Q4 2019 | $424,000 | -89.5% | 8,000 | -95.1% | 0.08% | -99.8% |
Q3 2015 | $4,036,000 | -21.3% | 162,070 | 0.0% | 43.03% | +27.1% |
Q2 2015 | $5,128,000 | +43.7% | 162,070 | +72.8% | 33.85% | +106.2% |
Q1 2015 | $3,569,000 | +64.2% | 93,781 | +68.2% | 16.42% | +413.1% |
Q4 2014 | $2,173,000 | +28.9% | 55,767 | 0.0% | 3.20% | +98.1% |
Q3 2014 | $1,686,000 | -11.0% | 55,767 | 0.0% | 1.62% | +1.7% |
Q2 2014 | $1,894,000 | +162.7% | 55,767 | +166.9% | 1.59% | +213.8% |
Q1 2014 | $721,000 | -72.4% | 20,892 | -68.3% | 0.51% | -80.1% |
Q4 2013 | $2,614,000 | – | 66,000 | – | 2.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |